Endocrine Flashcards
Obesity: Reversible causes
Drugs- antidepressant, steroids, progesterone
Polycystic ovarian syndrome
Hypogonadism
Growth hormone deficiency
Hypothyroidism
Genetic syndrome-Prader willi, Down and Turner syndrome
Obesity: Comorbidities and FHX
IHD/PVD
Diabetes
OSA
Hypertension
Hypertriglyceridemia
HYpercholesterolaemia
Smoking
Obesity: Complications
Osteoarthritis
Gallstones
Stress incontinence
Gout
Cancer risk - fat intake associated with COlorectal cancer and Prostate, Breast, endometrial and ovarian cancer
Obesity: Risk assessment-increased
BMI>30- obese,
Waist circumference:
>102 in male;
>88 in female
Obesity: management
Diet
Physical therapy
Behavioural therapy
Pharmacological therapy
Surgical
Diet
Aim to create a calorie deficit 500-1000kcal/day
Women 1000kcal-1200kcal
Men 1200-1600kcal
30% or less fat
15% protein
55% CHO
VLCD-Modifast/optifast -lose 10-20kg/3 months
420kcal/day
increased risk of gallstone and gout
must supplement with benefibre ( against constipation) and low calorie fluid ( 2-2.5L/day)
Physical therapy
30 minutes of moderate exercise daily.
Exercise that uses 150kcal/day or 1000kcal/week
Example: gardening 30-45mins, stair walking 15mins, walking 2.5km in 35 mins, onlyarms movement with weight for those in wheelchair or bobbing up and down on the seat for those really obese ( weigh >160kg)
Leaving bus stop 1 stop earlier, hydrotherapy and raking leaves.
Parking further than usual
walking up the stairs at work.
Seek to introduce new form of physical activity- cycling, boxing
Behavioural therapy
Seek to assess whether the weight loss has been sought on their initiative
Assess the events leading to a desire to lose weight ( physician to understand patient situation and motivation )
Patient understanding of the required treatment
Patient’s expectation of how much weight they can lose within a time period.
Discuss risky situation , precipitants for eating and learn the alternatives.
Pharmacological
BMI between 25-35 without complications ( DM, IHD)—->advise 3-6 months of lifestyle changes (diet, exercise) before considering medications and VLCD
Don’t forget to exclude OSA.
AIM: Weight loss of 10% of body weight /6 months— sustainable over 5 years at a rate of 1kg/week
As per up todate: GLP-1 agonist
SGLT-2 inh
Orlistat
Topiramate/
Super obese ( BMI > 40): What to do?
Important to achieve weigt stabilization
Patient this obese usually gain weight from immobilisation ( 6-12kg/year weight gain)
GLP-1 agonist- assist with satiety
VLCD / MODIFAST/OPTIFAST
BENEFITS: improved hypertension and lipid profile
450kcal/day-initially only VLCD then allow foods 1-2 normal meals
for 12-16 weeks only
Expect weight loss of 2kg/week
ADDITIONALLY: 2 LITRE OF WATER /DAY
BENEFIBRE- FOR FIBRE TO PREVENT CONSTIPATION
Side-effects: dry skin, hair loss, gout and increased hepatic enzymes
Diabetes Mellitus
Diagnosis:
HBA1c >6.8
Fasting BSL >7.0
2 hours post prandial/ glucose tolerance test >11.1
Diabetic foot ulcer ( PVD and PN)
Erectile dysfunction
Physical - health, effects of drugs and alcohol
Psychological
Physical- hypertension, diabetes, peripheral neuropathy
hypothyroidism, Hyercholesterolaemia, Obesity,
sleep apnoea, Stroke, cancer ( Prostate cancer-
85% of men with previous prostate cancer),
arthritis, parkinson disease. Thrombosis/ blood
clotting problems.
medications- beta blocker, antidepressants
Psychological- depression and anxiety, relationship issues
Treatment guidelines: